Activist 13D/13G Filings - Dyne Therapeutics Inc. (DYN)

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto 0, 1, Next
Reported
DateTime
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportFiling
2024-10-22
3:24 pm
Purchase
13GDyne Therapeutics Inc.
DYN
BlackRock Inc.7,794,217
7.8%
7,794,217increase
(New Position)
View
2024-04-04
7:04 pm
Purchase
13GDyne Therapeutics Inc.
DYN
RA CAPITAL MANAGEMENT L.P.5,213,661
6.4%
5,213,661increase
(New Position)
View
2024-02-14
4:57 pm
Purchase
13GDyne Therapeutics Inc.
DYN
CITADEL ADVISORS LLC3,072,587
5%
91,263increase
(+3.06%)
View
2024-02-14
08:39 am
Sale
13GDyne Therapeutics Inc.
DYN
Deep Track Capital LP2,000,000
3.26%
-2,500,000decrease
(-55.56%)
View
2024-02-12
4:06 pm
Sale
13GDyne Therapeutics Inc.
DYN
MPM BIOVENTURES 2018 L.P.3,451,303
4.3%
-1,519,596decrease
(-30.57%)
View
2024-02-09
4:09 pm
Purchase
13GDyne Therapeutics Inc.
DYN
Atlas Venture Fund XI L.P.7,342,083
9.1%
15,966increase
(+0.22%)
View
2024-01-29
3:26 pm
Purchase
13GDyne Therapeutics Inc.
DYN
BlackRock Inc.
BLK
3,788,682
6.2%
1,195,158increase
(+46.08%)
View
2024-01-19
4:38 pm
Purchase
13GDyne Therapeutics Inc.
DYN
Deep Track Capital LP4,500,000
5.55%
2,500,000increase
(+125.00%)
View
2024-01-19
09:08 am
Sale
13GDyne Therapeutics Inc.
DYN
Deep Track Capital LP2,000,000
3.26%
-684,200decrease
(-25.49%)
View
2023-02-14
4:29 pm
Unchanged
13GDyne Therapeutics Inc.
DYN
Atlas Venture Fund XI L.P.7,326,117
14.1%
0
(Unchanged)
View
2023-02-14
3:53 pm
Sale
13GDyne Therapeutics Inc.
DYN
Logos Global Management LP2,150,000
4.1%
-804,392decrease
(-27.23%)
View
2023-02-14
08:32 am
Sale
13GDyne Therapeutics Inc.
DYN
Deep Track Capital LP2,684,200
5.15%
-132,750decrease
(-4.71%)
View
2023-02-14
08:02 am
Purchase
13GDyne Therapeutics Inc.
DYN
CITADEL ADVISORS LLC2,981,324
5.7%
116,524increase
(+4.07%)
View
2023-02-10
4:31 pm
Sale
13DDyne Therapeutics Inc.
DYN
Vida Ventures II LLC2,220,034
4.3%
-740,012decrease
(-25.00%)
View
2023-02-09
4:04 pm
Purchase
13GDyne Therapeutics Inc.
DYN
MPM BIOVENTURES 2018 L.P.4,970,899
9.5%
19,596increase
(+0.40%)
View
2023-02-09
11:01 am
Sale
13GDyne Therapeutics Inc.
DYN
BlackRock Inc.
BLK
2,593,524
4.9%
-25,094decrease
(-0.96%)
View
2023-02-08
2:57 pm
Purchase
13GDyne Therapeutics Inc.
DYN
BlackRock Inc.
BLK
2,618,618
5%
2,618,618increase
(New Position)
View
2022-11-14
4:43 pm
Sale
13GDyne Therapeutics Inc.
DYN
RA CAPITAL MANAGEMENT L.P.0
0%
-2,805,045decrease
(Position Closed)
View
2022-02-14
4:11 pm
Unchanged
13GDyne Therapeutics Inc.
DYN
RA CAPITAL MANAGEMENT L.P.2,805,045
5.4%
0
(Unchanged)
View
2022-02-14
4:10 pm
Sale
13GDyne Therapeutics Inc.
DYN
Logos Global Management LP2,954,392
5.7%
-940,000decrease
(-24.14%)
View
Goto 0, 1, Next